Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Imunon, Inc. - Common Stock
(NQ:
IMNN
)
0.9100
+0.0800 (+9.64%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Imunon, Inc. - Common Stock
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Investor Forum: Now Available for Online Viewing
June 13, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
December 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Life Sciences Investor Forum Agenda Announced for June 11th-12th
June 10, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages
December 01, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022
November 22, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Announces Strategic Investment in Transomic Technologies
November 17, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
November 10, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
November 07, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Appoints James E. Dentzer to its Board of Directors
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Partial Results from Ongoing Non-human Primate Study
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
September 29, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
